Ligand Pharmaceuticals Inc (LGND)
Working Capital Ratio
64.52%
Quarterly · Period ending:
LGND Working Capital Ratio
Latest reported64.52%period ending
Latest reported64.52%period ending
LGND Quarterly Working Capital Ratio (77.55% → 64.52%)
Quarterly working capital ratio
High-resolution chart · PNG
LGND working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 64.5224% | |
| 53.831% | |
| 50.9295% | |
| 48.9839% | |
| 30.3826% | |
| 27.6809% | |
| 31.2651% | |
| 29.8069% | |
| 33.898% | |
| 38.4185% | |
| 28.0288% | |
| 30.9749% | |
| 32.6238% | |
| 28.2669% | |
| 21.6072% | |
| 8.1088% | |
| 7.0549% | |
| 21.1266% | |
| 32.6055% | |
| 31.0747% | |
| 28.5289% | |
| 26.3777% | |
| 29.3953% | |
| 65.3687% | |
| 67.1282% | |
| 68.3259% | |
| 74.0272% | |
| 74.1471% | |
| 73.998% | |
| 72.1592% | |
| 62.5229% | |
| 45.2041% | |
| 45.613% | |
| 13.5254% | |
| -0.2753% | |
| -1.1296% | |
| -4.4784% | |
| -8.3043% | |
| -10.6512% | |
| -14.2195% | |
| -15.205% | |
| 19.6954% | |
| 36.4723% | |
| 37.1997% | |
| 58.6609% | |
| 65.935% | |
| 62.9305% | |
| 66.1396% | |
| 9.9793% | |
| 11.7549% | |
| -3.8754% | |
| -15.565% | |
| -18.0786% | |
| -15.5312% | |
| -11.1414% | |
| -12.7633% | |
| -8.9135% | |
| -3.2756% | |
| -9.3282% | |
| -12.7684% | |
| -11.1241% | |
| -9.8947% | |
| 4.6732% | |
| -1.2375% | |
| -0.1536% | |
| 6.7003% | |
| 11.2787% | |
| 5.8487% | |
| 16.4644% | |
| 10.6106% | |
| 13.5989% | |
| 23.2786% | |
| 32.1829% | |
| 34.6363% | |
| 34.0349% | |
| 26.4476% | |
| 28.0664% | |
| 16.6624% | |
| 19.8578% | |
| -69.8193% | |
| -54.037% | |
| -49.7729% | |
| -32.4977% | |
| -34.925% | |
| -34.7799% | |
| -26.9798% | |
| -13.2007% | |
| 18.6383% | |
| 20.0973% | |
| 22.9934% | |
| 25.2636% | |
| 21.8375% | |
| 9.6148% | |
| 10.4438% | |
| 19.666% | |
| 17.5021% | |
| 23.1386% | |
| -22.8458% | |
| 18.5983% | |
| 23.0853% |